Low prevalence of hepatitis C virus RNA in blood donors with anti‐hepatitis C virus reactivity in Rwanda

Hepatitis C virus (HCV) is the leading cause of severe liver disease worldwide and is highly endemic in Africa, where it often has nosocomial spread. Little is known on the HCV prevalence, risk for transfusion‐transmitted HCV, and circulating genotypes in Rwanda. This study was performed to investigate the prevalence of anti‐HCV among blood donors from all regions of the country and genetically characterize identified HCV strains.

• Publication year

  2017

• Venue

  Transfusion

• Publication date

  2017-07-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/trf.14204PMID 28671283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EASL Recommendations on Treatment of Hepatitis C 2016.

  2017cited by this paper
• Hepatitis B virus strains from Rwandan blood donors are genetically similar and form one clade within subgenotype A1

  2017cited by this paper
• A Synthesis of Hepatitis C prevalence estimates in Sub-Saharan Africa: 2000–2013

  2016cited by this paper
• Advances in hepatitis C therapy: What is the current state - what come's next?

  2016cited by this paper
• The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.

  2016cited by this paper
• Hepatitis C Treatment Outcomes in Kigali, Rwanda

  2016influential reference
• Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need

  2016cited by this paper
• EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones.

  2016cited by this paper
• Factors associated with spontaneous clearance of chronic hepatitis C virus infection.

  2016cited by this paper
• Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta‐analysis

  2016cited by this paper
• Estimates on HCV disease burden worldwide – filling the gaps

  2015cited by this paper
• Increasing Access to Hepatitis C Treatment in Rwanda: The Promise ofRwandas Existing HIV Infrastructure

  2015cited by this paper
• Hepatitis C virus genotypes in Kenya

  2015influential reference
• Characterization of Hepatitis C Virus Recombination in Cameroon by Use of Nonspecific Next-Generation Sequencing

  2015cited by this paper
• Usefulness of a Fourth Generation ELISA Assay for the Reliable Identification of HCV Infection in HIV-Positive Adults from Gabon (Central Africa)

  2015cited by this paper
• The full-length genome sequences of nine HCV genotype 4 variants representing a new subtype 4s and eight unclassified lineages.

  2015cited by this paper
• Phylogeny and molecular evolution of the hepatitis C virus.

  2014cited by this paper
• Global epidemiology and genotype distribution of the hepatitis C virus infection.

  2014cited by this paper
• Global Distribution and Prevalence of Hepatitis C Virus Genotypes

  2014influential reference
• Natural history of hepatitis C.

  2014cited by this paper
• Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa

  2014cited by this paper
• Genotypes and subtypes of hepatitis C virus in Burundi: a particularity in Sub-saharan Africa

  2014influential reference
• The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

  2014cited by this paper
• Virology and cell biology of the hepatitis C virus life cycle: an update.

  2014cited by this paper
• Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence

  2013cited by this paper
• High frequency of false-positive hepatitis C virus enzyme-linked immunosorbent assay in Rakai, Uganda.

  2013cited by this paper
• Expanded Classification of Hepatitis C Virus Into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource

  2013cited by this paper
• Hepatitis C virus (HCV) infection in Africa: a review

  2013influential reference
• Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study.

  2012cited by this paper
• Recombination in Hepatitis C Virus: Identification of Four Novel Naturally Occurring Inter-Subtype Recombinants

  2012cited by this paper
• Phylogeography, Risk Factors and Genetic History of Hepatitis C Virus in Gabon, Central Africa

  2012cited by this paper
• Laboratory diagnostics for hepatitis C virus infection.

  2012cited by this paper
• Evolving epidemiology of hepatitis C virus.

  2011cited by this paper
• Risk Factors and Seroprevalence of Hepatitis C among Patients Hospitalized at Mulago Hospital, Uganda

  2011cited by this paper
• Assembly of infectious hepatitis C virus particles.

  2011cited by this paper
• Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.

  2010cited by this paper
• Double-antigen sandwich time-resolved immunofluorometric assay for the detection of anti-hepatitis C virus total antibodies with improved specificity and sensitivity.

  2008cited by this paper
• Hepatitis C Virus Genotype 4 in Ugandan Children and Their Mothers

  2006cited by this paper
• Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France.

  2005cited by this paper
• Visualizing Phylogenetic Trees Using TreeView

  2003cited by this paper
• Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon.

  2003cited by this paper
• Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa.

  2002cited by this paper
• Natural history of hepatitis C

  1997cited by this paper
• Inferring phylogenies from protein sequences by parsimony, distance, and likelihood methods.

  1996cited by this paper
• IgG interference in second generation enzymeimmunoassays for anti-hepatitis C virus antibodies.

  1993cited by this paper
• European Association for the Study of the Liver

  1971cited by this paper
• The natural history of hepatitis.

  1969cited by this paper

• Hepatitis C virus seroprevalence, testing, and treatment capacity in public health facilities in Ghana, 2016–2021; A multi-centre cross-sectional study

  2023cites this paper
• Hepatitis C virus among blood donors in Lubumbashi, DRC: seroprevalence and molecular characterisation.

  2023cites this paper
• A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmission

  2022cites this paper
• Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial.

  2022cites this paper
• Challenges in transfusion-transmitted infection screening in Sub-Saharan Africa.

  2021cites this paper
• Thalassemia Patients from Baluchistan in Pakistan Are Infected with Multiple Hepatitis B or C Virus Strains

  2021cites this paper
• High rate of hepatitis C virus and human immunodeficiency virus false‐positive results in serologic screening in sub‐Saharan Africa: adverse impact on the blood supply

  2019influential citation
• Screening a nation for hepatitis C virus elimination: a cross-sectional study on prevalence of hepatitis C and associated risk factors in the Rwandan general population

  2019influential citation
• Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trial.

  2019cites this paper
• Epidemiology, molecular characterization of hepatitis viruses in Rwanda and implication on liver disease

  2018cites this paper
• Towards a safe and sufficient blood supply in Sub‐Saharan Africa

  2018cites this paper